Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
COVID-19 Patient Resource Center
Clinical Trials
Search Clinical Trials
Patient Notification System
What is Clinical Research?
Volunteering for a Clinical Trial
Understanding Informed Consent
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Clinical Trial Listings
Market Research
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
JobWatch
White Papers
SOPs
eCFR and Guidances
White Papers
Trial Listings
Advertise
COVID-19
iConnect
Sign In
Create Account
Sign Out
My Account
Home
» Pipeline
Pipeline
October 1, 2018
Company
Drug/Device
Medical Condition
Status
Verastem
Copiktra
Leukemia
Granted approval by the FDA
MT.DERM GmbH
Exceed, microneedling device
Facial wrinkles
Granted clearance by the FDA
Cook Medical
5 mm diameter version of Zilver® PTX®
Peripheral artery disease (PAD)
Granted clearance by the FDA
Avita Medical
RECELL® Autologous Cell Harvesting Device (RECELL® System)
Severe thermal burns in patients 18 and older
Granted clearance by the FDA
Cardurion Pharmaceuticals
CRD-733, a Phosphodiesterase-9 (PDE-9) inhibitor
Heart failure
FDA has accepted Investigational New Drug Application (IND)
OBI Pharma, Inc.
OBI-3424
Acute Lymphoblastic Leukemia (ALL)
Granted Orphan Drug Designation by FDA
Alnylam Pharmaceuticals
Givosiran
Acute hepatic porphyrias (AHPs)
Successful early Phase III clinical trial results announced
AstraZeneca
Imfinzi (durvalumab)
Non-small cell lung cancer (NSCLC)
Phase III PACIFIC clinical trial found cut deaths by a third
Genentech
Tecentriq plus chemotherapy
Extensive-stage small cell lung cancer (ES-SCLC)
Phase III trial showed treatment helped patients live significantly longer than chemo alone
Daiichi Sankyo Company, Ltd
Trastuzumab deruxtecan (DS-8201)
Previously-treated HER2 positive unresectable and/or metastatic breast cancer
Initiated two Phase III trials
Aurinia Pharmaceuticals, Inc.
Voclosporin added to background therapy of mycophenolate mofetil (MMF)/CellCept®
Lupus nephritis (LN)
Completed enrollment in AURORA Phase III clinical trial
Catabasis Pharmaceuticals, Inc.
Edasalonexent
Duchenne muscular dystrophy (DMD)
Initiated Polaris DMD Phase III clinical trial
AstraZeneca
Farxiga (dapagliflozin)
Cardiovascular disease
Positive Phase III clinical trial results announced
Alexion Pharmaceuticals, Inc.
Soliris® (eculizumab)
Anti-aquaporin-4 (AQP4) auto antibody-positive neuromyelitis optica spectrum disorder (NMOSD)
Positive topline results from the Phase III PREVENT announced
Upcoming Events
24
May
Powering an Effective Oversight Strategy with Clinical and Operational Insights
25
May
2022 WCG Avoca Quality & Innovation Summit: Own the Future
28
Jun
Effective Root Cause Analysis and CAPA Investigations for the Life Sciences
16
Oct
WCG MAGI's Clinical Research Hybrid Conference - 2022 West
Featured Products
Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Featured Stories
Avoid Deviations by Making Protocol Review a Team Effort
Give Us a Voice: Sites Clamor for a Say on Vendor Selection
Use Data and Details to Convince Site Leadership to Add Staff
Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here
